Survivin in skin pathologies

Survivin-Induced Aurora-B Kinase Activation

(2010) Tao Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

XIAP is not required for human tumor cell survival in the absence of an exogenous death signal

(2010) John Sensintaffar et al.   BMC CANCER

Survivin Enhances Motility of Melanoma Cells by Supporting Akt Activation and  5 Integrin Upregulation

(2010) J. A. McKenzie et al.   CANCER RESEARCH

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

(2010) Redas Trepiakas et al.   CYTOTHERAPY

Concomitant inhibition of AKT and autophagy is required for efficient cisplatin-induced apoptosis of metastatic skin carcinoma

(2010) Sofie Claerhout et al.   INTERNATIONAL JOURNAL OF CANCER

Cleavage of Survivin by Granzyme M Triggers Degradation of the Survivin-X-linked Inhibitor of Apoptosis Protein (XIAP) Complex to Free Caspase Activity Leading to Cytolysis of Target Tumor Cells

(2010) Deqing Hu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cells

(2010) Chun Hei Antonio Cheung et al.   Molecular Cancer

Vitiligo and the melanocyte reservoir

(2010) Rafael Falabella   INDIAN JOURNAL OF DERMATOLOGY

Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions

(2009) Michel R Nasr et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma

(2009) Alvaro Lladser et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Survivin: A new target for anti-cancer therapy

(2009) Bríd M. Ryan et al.   CANCER TREATMENT REVIEWS

Mechanism of Drug Sensitivity and Resistance in Melanoma

(2009) Caterina La Porta   CURRENT CANCER DRUG TARGETS

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

(2009) Uta B. Hofmann et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Endogenous survivin modulates survival and proliferation in UVB-treated human keratinocytes

(2009) Katiuscia Dallaglio et al.   EXPERIMENTAL DERMATOLOGY

Exploring the role of stem cells in cutaneous wound healing

(2009) Katherine Lau et al.   EXPERIMENTAL DERMATOLOGY

Caspases and inhibitor of apoptosis proteins in cutaneous and mucosal melanoma: expression profile and clinicopathologic significance

(2009) Ni Chen et al.   HUMAN PATHOLOGY

Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literature

(2009) Mayumi Fujita et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

(2009) Karl D. Lewis et al.   INVESTIGATIONAL NEW DRUGS

VEGF, survivin and NOS overexpression in psoriatic skin: Critical role of nitric oxide synthases

(2009) Oriana Simonetti et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Epidermal homeostasis: a balancing act of stem cells in the skin

(2009) Cédric Blanpain et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Biomarkers in dysplasia of the oral cavity: A systematic review

(2009) Joel Smith et al.   ORAL ONCOLOGY

Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas

(2009) Laura Bongiovanni et al.   VETERINARY DERMATOLOGY

Review Paper: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells

(2009) J. E. Trosko   VETERINARY PATHOLOGY

Significance and relationship between Yes-associated protein and survivin expression in gastric carcinoma and precancerous lesions

(2009) Chun-Li Da   WORLD JOURNAL OF GASTROENTEROLOGY

Immunohistochemical Expression of Survivin in Cutaneous Sebaceous Lesions

(2008) Kenneth B Calder et al.   AMERICAN JOURNAL OF DERMATOPATHOLOGY

Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells

(2008) Jenilyn J. Virrey et al.   AMERICAN JOURNAL OF PATHOLOGY

Characterization of mesenchymal stem cells isolated from the human umbilical cord

(2008) S KESTENDJIEVA et al.   CELL BIOLOGY INTERNATIONAL

Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics

(2008) A. C. Mita et al.   CLINICAL CANCER RESEARCH

Tanning and Cutaneous Malignancy

(2008) SHERRIF F. IBRAHIM et al.   DERMATOLOGIC SURGERY

The Bcl-xL inhibitor of apoptosis is preferentially expressed in cutaneous squamous cell carcinoma compared with that in keratoacanthoma

(2008) Natasa Vasiljević et al.   INTERNATIONAL JOURNAL OF CANCER

Epidermal stem cells: location, potential and contribution to cancer

(2008) CA Ambler et al.   JOURNAL OF PATHOLOGY

Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance–associated protein genes

(2008) F. Jin et al.   NEUROSCIENCE

Rb/E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression

(2008) J Yang et al.   ONCOGENE

New wirings in the survivin networks

(2008) D C Altieri   ONCOGENE

Early Events in UV Carcinogenesis—DNA Damage, Target Cells and Mutant p53 Foci

(2008) Frank R. de Gruijl et al.   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Involvement of FKHRL1 in melanoma cell survival and death

(2008) C. Hilmi et al.   Pigment Cell & Melanoma Research

Chemically synthesized human survivin does not inhibit caspase-3

(2008) Changqing Li et al.   PROTEIN SCIENCE

Evaluation of survivin and NF-κB in psoriasis, an immunohistochemical study

(2007) Asmaa Gaber Abdou et al.   JOURNAL OF CUTANEOUS PATHOLOGY

IGF1 Promotes Resistance to Apoptosis in Melanoma Cells through an Increased Expression of BCL2, BCL-X(L), and Survivin

(2007) Caroline Hilmi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY